Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints.

MLA

Molica, Stefano. “Defining Treatment Success in Chronic Lymphocytic Leukemia: Exploring Surrogate Markers, Comorbidities, and Patient-Centered Endpoints.” Expert Review of Hematology, vol. 17, no. 7, July 2024, pp. 279–85. EBSCOhost, https://doi.org/10.1080/17474086.2024.2366534.

APA

Molica, S. (2024). Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints. Expert Review of Hematology, 17(7), 279–285. https://doi.org/10.1080/17474086.2024.2366534

Chicago

Molica, Stefano. 2024. “Defining Treatment Success in Chronic Lymphocytic Leukemia: Exploring Surrogate Markers, Comorbidities, and Patient-Centered Endpoints.” Expert Review of Hematology 17 (7): 279–85. doi:10.1080/17474086.2024.2366534.